$ME /USDT is trading at approximately $3.17 USD per share
In October 2024 .23 and Me implemented a 1 for 20 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement
In November 2024, the company announced a 40% workforce reduction and the discontinuation of its therapeutic programs to focus on its core consumer genetics business
